Table 2.
Prearrest electrocardiographic characteristics and contributors
Case | Rhythm | Rate (beats/min) | Intervals (ms) | ST/T-wave changes | Pressors | Antiarrhythmics | QT-prolonging drugs | |
---|---|---|---|---|---|---|---|---|
1 | Sinus tachycardia | 130 | PR – 148 QRSd – 102 QT – 304 QTc – 447 |
Peaked T waves | None | Metoprolol | Chlordiazepoxide Hydromorphone |
|
2 | Sinus rhythm | 66 | PR – 142 QRSd – 92 QT – 420 QTc – 440 |
Nonspecific | None | None | Hydroxychloroquine Azithromycin Hydromorphone |
|
3 | Sinus rhythm | 99 | PR – 138 QRSd – 78 QT – 344 QTc – 441 |
None | Norepinephrine Vasopressin |
None | Hydroxychloroquine Chlordiazepoxide Hydromorphone |
|
4 | Sinus tachycardia | 107 | PR – 154 QRSd – 90 QT – 338 QTc – 451 |
None | Epinephrine Norepinephrine Vasopressin |
Amiodarone | Hydroxychloroquine Azithromycin |
|
5 | Sinus rhythm | 90 | PR – 122 QRSd – 82 QT – 394 QTc – 481 |
Lateral ST depressions | None | None | None |